Monoamines oxidase (MAO) is one of the enzymes responsible for the catabolism of various biogenic individuals that the concentration of various biogenic amines is diminished. Consequently, compounds that inhibit Or inactivate MAO A, the isozyme that selectively degrades norepinephrine and serotonin, exhibit antidepressant activity. Because of the importance Of maintaining a high concentration of dopamine in the brains of those afflicted with Parkinson disease, compounds that inactivate MAO B, the isozyme that degrades dopamine, are used in the treatment of Parkinson's disease.
The specific aims for this project period are (i) to design new inactivators for MAO and elucidate the inactivation mechanisms of these compounds; (2) to further investigate the mechanism of MAO; and (3) to identify, at least, some of the residues in the active site of MAO. The new inactivators include 4-methylthiobenzyl amine, 4-substituted-dihydropyridines, N-(2- methylenecyclopropyl)benzylamine, and a series of new heterocyclic potential inactivators of MAO. Mechanistic information will be obtained with the use of pyridine N-oxides as potential intramolecular radical traps, and by investigating the possible involvement of an active site disulfide in MAO-catalyzed oxidations. Active site structural information will be obtained by several approaches: with NMR studies of the active site labeled with 1-phenylcyclopropylamine and tranylcypromine; with classical peptide mapping following inactivation by several mechanism-based inactivators; with polymer-supported enzyme inactivation to obtain active site residue information more efficiently; with biotin- inactivator enzyme inactivation, again to gain active site residue information more quickly; by investigating the structure of the modified flavin using NMR and mass spectral techniques after inactivation of a new fungal monoamine oxidase, MAO N; by utilizing the structural information from MAO N to elucidate the modified flavin structures after inactivation of MAO B; and with an attempted crystal structure of MAO B. We also will investigate the stereoselectivity of ring cleavage of 1-phenylcyclobutylamine and determine the potential stereoselectivity of MAO-catalyzed oxidations in organic solvents and the use of MAO in catalyzing the oxidation of hydrophobic molecules in organic solvents.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM032634-22
Application #
6385512
Study Section
Bio-Organic and Natural Products Chemistry Study Section (BNP)
Program Officer
Schwab, John M
Project Start
1983-04-01
Project End
2003-03-31
Budget Start
2001-04-01
Budget End
2002-03-31
Support Year
22
Fiscal Year
2001
Total Cost
$310,116
Indirect Cost
Name
Northwestern University at Chicago
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
City
Evanston
State
IL
Country
United States
Zip Code
60201
Vintem, Ana Paula B; Price, Nigel T; Silverman, Richard B et al. (2005) Mutation of surface cysteine 374 to alanine in monoamine oxidase A alters substrate turnover and inactivation by cyclopropylamines. Bioorg Med Chem 13:3487-95
Schering, Christine A; Zhong, Boyu; Woo, Jonathan C G et al. (2004) Poly(ethylene glycol)-supported enzyme inactivators. Efficient identification of the site of covalent attachment to alpha-chymotrypsin by PEG-TPCK. Bioconjug Chem 15:673-6
Lu, Xingliang; Rodriguez, Maria; Gu, Wenxin et al. (2003) Inactivation of mitochondrial monoamine oxidase B by methylthio-substituted benzylamines. Bioorg Med Chem 11:4423-30
Lu, Xingliang; Nikolic, Dejan; Mitchell, Deanna J et al. (2003) A mechanism for substrate-Induced formation of 6-hydroxyflavin mononucleotide catalyzed by C30A trimethylamine dehydrogenase. Bioorg Med Chem Lett 13:4129-32
Lee, Younghee; Ling, Ke-Qing; Lu, Xingliang et al. (2002) 3-pyrrolines are mechanism-based inactivators of the quinone-dependent amine oxidases but only substrates of the flavin-dependent amine oxidases. J Am Chem Soc 124:12135-43
Mitchell, D J; Nikolic, D; van Breemen, R B et al. (2001) Inactivation of monoamine oxidase B by 1-phenylcyclopropylamine: mass spectral evidence for the flavin adduct. Bioorg Med Chem Lett 11:1757-60
Mitchell, D J; Nikolic, D; Rivera, E et al. (2001) Spectrometric evidence for the flavin-1-phenylcyclopropylamine inactivator adduct with monoamine oxidase N. Biochemistry 40:5447-56
Mitchell, D J; Nikolic, D; Jang, M H et al. (2001) Inactivation of C30A trimethylamine dehydrogenase by N-cyclopropyl-alpha-methylbenzylamine, 1-phenylcyclopropylamine, and phenylhydrazine. Biochemistry 40:8523-30
Woodroofe, C C; Mostashari, R; Lu, X et al. (2000) Selective inhibition of monoamine oxidase B by aminoethyl substituted benzyl ethers. J Enzyme Inhib 15:21-Nov
Wang, X; Silverman, R B (2000) Monoamine oxidase-catalyzed oxidation of endo,endo-2-amino-6-[(Z)-2'-phenyl]ethenylbicyclo[2.2.1]heptane, a potential probe for a radical cation intermediate. Bioorg Med Chem 8:1645-51

Showing the most recent 10 out of 37 publications